I can give props when it’s due. I saw this ad today in Internal Medicine News (ok, not really directed at consumers). But for once, it has some redeemable qualities, alerting readers about the potential for prescribing errors between Amaryl and Reminyl.
Related posts:
- Drug companies responsible for generic side effects?
- The waning effect of direct to consumer drug advertising
- Academia responsible for the primary care shortage?
- Who is responsible for an abnormality on pre-operative testing, or, aren’t radiologists doctors too?
- Is the doctor or patient responsible for celebrity drug overdoses?
- Does e-prescribing save prescription drug costs?
- A bad day for New Hampshire drug reps
KevinMD.com on Facebook
Comments on this entry are closed.